| scholarly article | Q13442814 |
| P50 | author | Patricia D'Amore | Q30323567 |
| Magali Saint-Geniez | Q58898025 | ||
| P2093 | author name string | Tony Walshe | |
| Alisar Zahr | |||
| Knatokie M Ford | |||
| P2860 | cites work | Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress | Q24561521 |
| VEGF inhibition and renal thrombotic microangiopathy | Q24632792 | ||
| The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding | Q27746636 | ||
| Cellular retinaldehyde-binding protein interacts with ERM-binding phosphoprotein 50 in retinal pigment epithelium | Q28240909 | ||
| ARPE-19, a human retinal pigment epithelial cell line with differentiated properties | Q28283979 | ||
| Polarity and developmental regulation of two PDZ proteins in the retinal pigment epithelium | Q28569767 | ||
| Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. | Q28583917 | ||
| Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function | Q28590458 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy | Q30642886 | ||
| RPE tears after pegaptanib treatment in age-related macular degeneration | Q33300082 | ||
| Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors | Q33382103 | ||
| Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis | Q34729610 | ||
| Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia | Q34731351 | ||
| Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis | Q35575003 | ||
| Glomerular endothelial cell differentiation. | Q36102370 | ||
| Mosaicism of the retinal pigment epithelium: seeing the small picture | Q36241152 | ||
| Ezrin promotes morphogenesis of apical microvilli and basal infoldings in retinal pigment epithelium | Q36326132 | ||
| VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma | Q36502881 | ||
| An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris | Q37413610 | ||
| Multiple functions for Pax6 in mouse eye and nasal development. | Q38361697 | ||
| Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis | Q39784273 | ||
| Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials | Q39830867 | ||
| Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). | Q40276294 | ||
| Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. | Q40295316 | ||
| Gene expression profiles of mouse retinas during the second and third postnatal weeks | Q40315875 | ||
| Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. | Q41829449 | ||
| RPE destruction causes choriocapillary atrophy. | Q42458037 | ||
| Microvilli defects in retinas of ezrin knockout mice | Q42486471 | ||
| Intracellular bevacizumab reduces phagocytotic uptake in RPE cells | Q43156907 | ||
| Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt | Q43260495 | ||
| Cytoskeletons of retinal pigment epithelial cells: interspecies differences of expression patterns indicate independence of cell function from the specific complement of cytoskeletal proteins | Q43411173 | ||
| The distribution of F-actin in cells isolated from vertebrate retinas | Q43495533 | ||
| Regulation of choroid development by the retinal pigment epithelium. | Q43820569 | ||
| Retinal pigment epithelium tears after bevacizumab injection | Q44779837 | ||
| VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature | Q46231250 | ||
| Non-hypoxic induction of HIF-3alpha by 2-deoxy-D-glucose and insulin | Q48358959 | ||
| Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. | Q52175349 | ||
| Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. | Q54151586 | ||
| VEGF expression and receptor activation in the choroid during development and in the adult. | Q54595229 | ||
| Molecular heterogeneity of the actin filament cytoskeleton associated with microvilli of photoreceptors, Müller's glial cells and pigment epithelial cells of the retina | Q70648365 | ||
| Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model | Q79826280 | ||
| Long-term follow-up after multiple intravitreal bevacizumab injections for exudative age-related macular degeneration | Q82864929 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9478-9487 | |
| P577 | publication date | 2011-12-09 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Expression and role of VEGF in the adult retinal pigment epithelium | |
| P478 | volume | 52 |
| Q36290925 | A Systematic Approach to Identify Candidate Transcription Factors that Control Cell Identity |
| Q41817953 | A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization |
| Q27318539 | AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization |
| Q46483060 | Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells |
| Q36727687 | Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence |
| Q26826870 | Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind |
| Q93155245 | Choroidal Patterns in Stargardt Disease: Correlations with Visual Acuity and Disease Progression |
| Q99630479 | Choroidal Thickness in Different Types of Inherited Retinal Dystrophies |
| Q94686967 | Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration |
| Q42129632 | Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size |
| Q54336106 | Comparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture. |
| Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
| Q64057818 | Dietary Polyphenols in Age-Related Macular Degeneration: Protection against Oxidative Stress and Beyond |
| Q33773175 | Effects of bevacizumab on endoplasmic reticulum stress in hypoxic retinal pigment epithelial cells |
| Q49343847 | Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling |
| Q39636372 | Epithelial-mesenchymal transition of the retinal pigment epithelium causes choriocapillaris atrophy |
| Q36383625 | Expression and role of VEGF--a in the ciliary body. |
| Q35294211 | Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells |
| Q38654588 | Gene therapy for age-related macular degeneration. |
| Q37354230 | Genomic Disruption of VEGF-A Expression in Human Retinal Pigment Epithelial Cells Using CRISPR-Cas9 Endonuclease. |
| Q36267888 | Human Adult Retinal Pigment Epithelial Stem Cell-Derived RPE Monolayers Exhibit Key Physiological Characteristics of Native Tissue |
| Q38973154 | Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases |
| Q41983406 | Identification of a synergistic interaction between endothelial cells and retinal pigment epithelium |
| Q87225422 | Intravitreal vascular endothelial growth factor |
| Q38946467 | Involvement of endoplasmic reticulum stress in all-trans-retinal-induced retinal pigment epithelium degeneration. |
| Q39207485 | Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia |
| Q47108998 | Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration. |
| Q51248665 | Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. |
| Q27000182 | Mechanisms of age-related macular degeneration |
| Q39379380 | Molecular regulation of vascular endothelial growth factor expression in the retinal pigment epithelium. |
| Q33785965 | Morphological changes in spectral domain optical coherence tomography guided bevacizumab injections in wet age-related macular degeneration, 12-months results |
| Q36530569 | NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration |
| Q35830419 | Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice |
| Q91045781 | Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE |
| Q64929635 | Optimization of an in vitro bilayer model for studying the functional interplay between human primary retinal pigment epithelial and choroidal endothelial cells isolated from donor eyes. |
| Q35964977 | Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells. |
| Q38183850 | Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF. |
| Q38696031 | Physical disruption of cell-cell contact induces VEGF expression in RPE cells |
| Q38644369 | Pomegranate protective effect on experimental ischemia/reperfusion retinal injury in rats (histological and biochemical study). |
| Q53594408 | Ranibizumab for subfoveal choroidal neovascularisation associated with Stargardt disease. |
| Q41926961 | Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. |
| Q26751293 | Regulation of signaling events involved in the pathophysiology of neovascular AMD |
| Q36904040 | Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy |
| Q42153332 | Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy |
| Q92030152 | Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD |
| Q36376302 | Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse |
| Q34003273 | Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms |
| Q53116651 | The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys. |
| Q36828146 | The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye. |
| Q38669043 | The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook. |
| Q35018565 | Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration |
| Q54571267 | Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis. |
| Q97867234 | VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons |
| Q38779268 | VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. |
| Q37022876 | Vascular endothelial growth factor is important for brown adipose tissue development and maintenance. |
| Q61053743 | Zika virus induces strong inflammatory responses and impairs homeostasis and function of the human retinal pigment epithelium |
| Q53018746 | [Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?] |
Search more.